Production (Stage)
Lipella Pharmaceuticals Inc.
LIPO
$2.99
-$0.10-3.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.13M | -5.02M | -4.26M | -4.14M | -4.74M |
| Total Depreciation and Amortization | 3.50K | 3.50K | 3.50K | 3.80K | 2.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 540.10K | 948.70K | 868.00K | 908.60K | 1.67M |
| Change in Net Operating Assets | 599.00K | 113.30K | -296.10K | -494.20K | -390.80K |
| Cash from Operations | -3.99M | -3.95M | -3.69M | -3.72M | -3.46M |
| Capital Expenditure | -- | -- | 0.00 | -14.40K | -14.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -14.40K | -14.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -250.00K |
| Issuance of Common Stock | 6.11M | 2.84M | 2.63M | 1.81M | 1.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.11M | 2.84M | 2.63M | 1.81M | 1.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 2.12M | -1.11M | -1.06M | -1.93M | -1.91M |